View Older Stories View More Recent Stories

Apr 29, 2026 07:00AM Oruka Therapeutics (ORKA) PT Raised to $120 at H.C. Wainwright
Apr 27, 2026 04:12PM Oruka Therapeutics (ORKA) PT Raised to $131 at Clear Street
Apr 27, 2026 12:19PM Oruka Therapeutics (ORKA) PT Raised to $160 at Barclays
Apr 27, 2026 11:24AM Oruka Therapeutics (ORKA) PT Raised to $200 at Guggenheim
Apr 27, 2026 10:10AM Oruka Therapeutics (ORKA) PT Raised to $165 at Wedbush
Apr 27, 2026 10:06AM Oruka Therapeutics (ORKA) PT Raised to $151 at BTIG
Apr 27, 2026 09:36AM Oruka Therapeutics (ORKA) PT Raised to $150 at Stifel
Apr 27, 2026 07:17AM Stifel on Oruka Therapeutics (ORKA): 'We expect shares to trade meaningfully-higher'
Apr 20, 2026 08:51AM TD Cowen on Oruka Therapeutics (ORKA): '39-49% Or Higher PASI 100 Should Unlock Multi-Billion Sales'
Apr 15, 2026 07:19AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
Apr 13, 2026 06:40AM Oruka Therapeutics (ORKA) PT Raised to $70 at H.C. Wainwright
Apr 13, 2026 05:51AM Oruka Therapeutics (ORKA) PT Raised to $78 at BTIG
Apr 8, 2026 04:42PM Stifel stays Buy on Oruka Therapeutics (ORKA) after Ph2a data from EVERLAST-A study
Apr 6, 2026 09:27AM UBS Reiterates Buy Rating on Oruka Therapeutics (ORKA) Following Data Readout
Apr 6, 2026 06:42AM Oruka Therapeutics (ORKA) PT Raised to $125 at Guggenheim
Apr 2, 2026 04:11PM Oruka Therapeutics (ORKA) files $1B mixed shelf
Mar 26, 2026 06:23AM Oruka Therapeutics (ORKA) PT Raised to $109 at Leerink Partners
Mar 24, 2026 08:56AM Piper Sandler on Oruka Therapeutics (ORKA): 'Now Is the Time to Own the Name'
Mar 13, 2026 09:26AM BTIG Reiterates Buy Rating on Oruka Therapeutics (ORKA): 'Commercial Precedents Continue to Read Through Positively to ORKA-001/2'
Mar 12, 2026 05:53PM Oruka Therapeutics (ORKA) PT Raised to $72 at Stifel
Mar 12, 2026 05:19PM Oruka Therapeutics (ORKA) Misses Q4 EPS by 45c
Jan 13, 2026 05:09AM Oruka Therapeutics (ORKA) PT Raised to $71 at Clear Street
Jan 7, 2026 12:50AM UBS Starts Oruka Therapeutics (ORKA) at Buy
Dec 18, 2025 04:02AM Piper Sandler Starts Oruka Therapeutics (ORKA) at Overweight
Dec 11, 2025 04:01PM Oruka Therapeutics adds Chris Martin to board, Cameron Turtle resigns
Nov 13, 2025 06:32AM Oruka Therapeutics (ORKA) Misses Q3 EPS by 55c
Nov 13, 2025 04:29AM Oruka Therapeutics (ORKA) PT Raised to $63 at BTIG
Nov 13, 2025 04:03AM Jefferies Starts Oruka Therapeutics (ORKA) at Buy
Oct 27, 2025 06:49AM Oruka Therapeutics (ORKA) PT Lowered to $40 at H.C. Wainwright
Oct 27, 2025 06:13AM Guggenheim Starts Oruka Therapeutics (ORKA) at Buy
Oct 14, 2025 04:48PM Oruka Therapeutics (ORKA) files for 39.43M share offering by selling stockholders
Oct 14, 2025 04:48PM Oruka Therapeutics (ORKA) files $500M mixed shelf
Oct 13, 2025 05:31AM Barclays Starts Oruka Therapeutics (ORKA) at Overweight
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
Sep 17, 2025 03:37PM Oruka Therapeutics (ORKA) PT Raised to $56 at BTIG
Aug 20, 2025 04:33PM Clear Street Starts Oruka Therapeutics (ORKA) at Buy
Aug 12, 2025 05:04AM BTIG Reiterates Buy Rating on Oruka Therapeutics (ORKA)
Aug 11, 2025 04:48PM Oruka Therapeutics (ORKA) Misses Q2 EPS by 46c
Jul 23, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
Jul 21, 2025 08:03AM Stifel Reiterates Buy Rating on Oruka Therapeutics (ORKA)
Jul 1, 2025 04:01PM Oruka Therapeutics (ORKA) Appoints Laura Sandler as COO
May 27, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
May 22, 2025 06:07AM BTIG Starts Oruka Therapeutics (ORKA) at Buy
May 20, 2025 04:01PM Oruka Therapeutics (ORKA) Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody
May 14, 2025 06:28PM Oruka Therapeutics (ORKA) Misses Q1 EPS by 40c
Mar 7, 2025 07:41AM Stifel Reiterates Buy Rating on Oruka Therapeutics (ORKA)
Mar 6, 2025 05:18PM Oruka Therapeutics (ORKA) Misses Q4 EPS by 49c
Dec 20, 2024 06:52AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
Nov 25, 2024 06:45AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
View More Recent Stories View Older Stories